section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

GI: transaminases

Local: injection site reactions

Neuro: dizziness

Misc: fever

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

US Brand Names

Firazyr

Action

  • Antagonizes the effects of bradykinin which are responsible for symptoms of HAE.
Therapeutic effects:

Classifications

Therapeutic Classification: hereditary angioedema agents

Pharmacologic Classification: bradykinin B2 receptor antagonists

Pharmacokinetics

Absorption: 97% absorbed following SUBQ administration.

Distribution: Unknown.

Metabolism/Excretion: Metabolized systemically by proteolytic enzymes to metabolites that are renally excreted; <10% excreted unchanged in urine.

Half-Life: 1.4 hr.

Time/Action Profile

(reduction of symptoms)

ROUTEONSETPEAKDURATION
SUBQwithin 1 hr2.0–2.6 hr6–8 hr

50% reduction in baseline symptoms.

Patient/Family Teaching

Pronunciation

eye-KAT-i-bant

Code

NDC Code